Yekeduz, E. Et Al. 2022. Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.78, no.12 , 1973-1979.

Yekeduz, E., ÖZBAY, M. F., Caglayan, D., YILDIRIM, A., Erol, C., YILDIRIM, H. Ç., ... Tunc, S.(2022). Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study. EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.78, no.12, 1973-1979.

Yekeduz, Emre Et Al. "Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study," EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.78, no.12, 1973-1979, 2022

Yekeduz, Emre Et Al. "Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study." EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.78, no.12, pp.1973-1979, 2022

Yekeduz, E. Et Al. (2022) . "Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study." EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY , vol.78, no.12, pp.1973-1979.

@article{article, author={Emre Yekeduz Et Al. }, title={Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study}, journal={EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY}, year=2022, pages={1973-1979} }